Michelle Sylvanowicz

Michelle Sylvanowicz is an experienced professional in the pharmaceutical industry, specializing in ophthalmology. She currently holds the position of Director of Global Advocacy, Ophthalmology at Bayer Pharmaceuticals.13 With a demonstrated history of working in the pharmaceuticals industry and the ophthalmology space, Sylvanowicz has established herself as a seasoned expert in her field.1

Throughout her career, Sylvanowicz has shown a strong commitment to advocacy, particularly in the area of retinal care. Her passion for patients and partnerships is evident in her professional endeavors.2 Prior to her current role at Bayer, she held the position of Senior Director at Regeneron Pharmaceuticals, Inc., where she was involved in advancements in retinal care, such as the development of Eylea HD.2

Sylvanowicz's LinkedIn profile, under the username michelle-sylvanowicz-275b397, reflects her professional journey and expertise in global advocacy within the ophthalmology sector.1 Her role involves working with various stakeholders to promote advancements in eye care and support patient needs in the field of ophthalmology.

Based in Basel, Switzerland, Michelle Sylvanowicz continues to contribute significantly to the pharmaceutical industry, particularly in the realm of global advocacy for ophthalmology.3